Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytosolic DNA sensing by cGAS: regulation, function, and human diseases. | Signal Transduct Target Ther | 2021 | 33927185 | PubTator, text mining | PubMed |
| Ibrutinib combinations in CLL therapy: scientific rationale and clinical results. | Blood Cancer J | 2021 | 33927183 | PubTator, text mining | PubMed |
| PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection-"Rheumatic Fever" of the 21st Century? | Int J Mol Sci | 2021 | 33925779 | PubTator, text mining | PubMed |
| Advances in Lupus Nephritis Pathogenesis: From Bench to Bedside. | Int J Mol Sci | 2021 | 33916456 | PubTator, text mining | PubMed |
| SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? | J Exp Med | 2021 | 33904890 | PubTator, text mining | PubMed |
| Current and future treatment strategies in chronic lymphocytic leukemia. | J Hematol Oncol | 2021 | 33902665 | PubTator, text mining | PubMed |
| Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules. | BMC Endocr Disord | 2021 | 33902539 | PubTator, text mining | PubMed |
| Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations. | PLoS One | 2021 | 33901204 | PubTator, text mining | PubMed |
| EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines. | Sci Rep | 2021 | 33883672 | PubTator, text mining | PubMed |
| BCL11B is positioned upstream of PLZF and RORγt to control thymic development of mucosal-associated invariant T cells and MAIT17 program. | iScience | 2021 | 33870128 | PubTator, text mining | PubMed |
| Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape. | Front Immunol | 2021 | 33868274 | PubTator, text mining | PubMed |
| Exploring the Role of Epicardial Adipose Tissue in Coronary Artery Disease From the Difference of Gene Expression. | Front Physiol | 2021 | 33859569 | PubTator, text mining | PubMed |
| A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast! | Am J Respir Crit Care Med | 2021 | 33856964 | PubTator, text mining | PubMed |
| Polishing the crystal ball: mining multi-omics data in dermatomyositis. | Ann Transl Med | 2021 | 33842656 | PubTator, text mining | PubMed |
| Exploring a Region on Chromosome 8p23.1 Displaying Positive Selection Signals in Brazilian Admixed Populations: Additional Insights Into Predisposition to Obesity and Related Disorders. | Front Genet | 2021 | 33841501 | PubTator, text mining | PubMed |
| The Dual Regulation of Apoptosis by Flavivirus. | Front Microbiol | 2021 | 33841381 | PubTator, text mining | PubMed |
| Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells. | Front Endocrinol (Lausanne) | 2021 | 33841333 | PubTator, text mining | PubMed |
| Transcriptomic studies of systemic lupus erythematosus. | Inflamm Regen | 2021 | 33836832 | PubTator, text mining | PubMed |
| Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. | Leukemia | 2021 | 33833385 | PubTator, text mining | PubMed |
| Genomic analysis of pancreatic cancer reveals 3 molecular subtypes with different clinical outcomes. | Medicine (Baltimore) | 2021 | 33832071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=39